165 related articles for article (PubMed ID: 24259703)
1. Acute ischemic stroke following cardioversion in a patient receiving dabigatran.
Faust AC; Smith MB; Kawalsky D
Ann Pharmacother; 2013 Oct; 47(10):1368-71. PubMed ID: 24259703
[TBL] [Abstract][Full Text] [Related]
2. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
3. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
Tkacheva ON; Akasheva DU
Ter Arkh; 2014; 86(4):103-7. PubMed ID: 24864477
[TBL] [Abstract][Full Text] [Related]
4. [Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran].
Amara W; Guedeney P; Iusuf A
Ann Cardiol Angeiol (Paris); 2013 Nov; 62(5):358-60. PubMed ID: 24054444
[TBL] [Abstract][Full Text] [Related]
5. New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.
Barrios V; Escobar C
Expert Opin Pharmacother; 2012 Dec; 13(18):2649-61. PubMed ID: 23167273
[TBL] [Abstract][Full Text] [Related]
6. [Waiting for the new oral anticoagulants: questions and answers about dabigatran].
Verdecchia P; Agnelli G
G Ital Cardiol (Rome); 2013 Jan; 14(1):35-45. PubMed ID: 23258203
[TBL] [Abstract][Full Text] [Related]
7. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
[TBL] [Abstract][Full Text] [Related]
8. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Sangha N; El Khoury R; Misra V; Lopez G
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
[TBL] [Abstract][Full Text] [Related]
9. [Extensive thromboembolism after cardioversion in a patient treated with dabigatran].
Buch TN; Holm J; Munck LK
Ugeskr Laeger; 2013 Feb; 175(6):333-4. PubMed ID: 23402235
[TBL] [Abstract][Full Text] [Related]
10. Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
Gagliardi L; Guerbaai RA; Marlière S; Bouvaist H; Ennezat PV
Int J Cardiol; 2014 Aug; 175(3):571-2. PubMed ID: 24861253
[No Abstract] [Full Text] [Related]
11. [Direct oral thrombin inhibitor, "dabigatran"].
Yasaka M
Nihon Rinsho; 2013 Jan; 71(1):113-8. PubMed ID: 23631181
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutter.
Zylla MM; Pohlmeier M; Hess A; Mereles D; Kieser M; Bruckner T; Scholz E; Zitron E; Schweizer PA; Katus HA; Thomas D
Am J Cardiol; 2015 Mar; 115(5):635-40. PubMed ID: 25591898
[TBL] [Abstract][Full Text] [Related]
13. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
Bendel SD; Bona R; Baker WL
Adv Ther; 2011 Jun; 28(6):460-72. PubMed ID: 21533567
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and clinical implications of dabigatran use in severe renal impairment for stroke prevention in nonvalvular atrial fibrillation.
Mack DR; Kim JJ
Ann Pharmacother; 2012; 46(7-8):1105-10. PubMed ID: 22764329
[TBL] [Abstract][Full Text] [Related]
15. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
16. Intravenous thrombolysis in a stroke patient taking dabigatran.
Lee VH; Conners JJ; Prabhakaran S
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
[TBL] [Abstract][Full Text] [Related]
17. [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?].
Calvo Romero JM
Rev Clin Esp; 2011 Mar; 211(3):142-6. PubMed ID: 21371701
[TBL] [Abstract][Full Text] [Related]
18. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]